Galmed Pharmaceuticals (GLMD) Change in Acquisitions & Divestments (2014 - 2026)

Galmed Pharmaceuticals' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $825000.0 for Q4 2025.

• In Q4 2025, Change in Acquisitions & Divestments fell 33.31% year-over-year to $825000.0; the TTM figure through Dec 2025 stood at $3.2 million (down 8.1% YoY), while the FY2025 annual figure was $1.6 million, down 70.73% from the prior year.
• Change in Acquisitions & Divestments for Q4 2025 stood at $825000.0, down from $1.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $17.4 million in Q4 2021, with the low at -$214000.0 in Q4 2023.
• The 5-year median for Change in Acquisitions & Divestments is $1.3 million (2023), against an average of $4.9 million.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments slumped 103.82% in 2023, then surged 678.04% in 2024.
• Galmed Pharmaceuticals' Change in Acquisitions & Divestments stood at $17.4 million in 2021, then slumped by 67.91% to $5.6 million in 2022, then plunged by 103.82% to -$214000.0 in 2023, then soared by 678.04% to $1.2 million in 2024, then sank by 33.31% to $825000.0 in 2025.
• Business Quant data shows GLMD's Change in Acquisitions & Divestments at $825000.0 in Q4 2025, $1.2 million in Q4 2024, and $1.2 million in Q3 2024.